Lee, Danner & Bass’s Gilead Sciences GILD Stock Holding History

Lee, Danner & Bass’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-440	Closed	-$40.6K	–	409
2024 Q4	$40.6K	Buy	+440	New	+$39.6K	﹤0.01%	369

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lee, Danner & Bass's GILD Position: Q1 2025 in Review

Lee, Danner & Bass sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 440 shares — an estimated $40.6K sold.

Lee, Danner & Bass first reported a position in GILD in Q4 2024 and held it in 1 quarter. The position peaked at $40.6K in Q4 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Lee, Danner & Bass reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Lee, Danner & Bass sold 440 Gilead Sciences shares in Q1 2025, an estimated $40.6K.
Lee, Danner & Bass first reported a position in Gilead Sciences in Q4 2024 and held it in 1 quarter.
Lee, Danner & Bass's Gilead Sciences position peaked at $40.6K in Q4 2024.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.